Search Results - "Azzariti, Amalia"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study by Porcelli, Letizia, Garofoli, Marianna, Di Fonte, Roberta, Fucci, Livia, Volpicella, Mariateresa, Strippoli, Sabino, Guida, Michele, Azzariti, Amalia

    Published in Scientific reports (26-06-2020)
    “…Standard chemotherapy for soft tissue sarcomas has shown limited efficacy. Here, we sought to evaluate whether β-adrenergic receptor (β-AR) signalling…”
    Get full text
    Journal Article
  5. 5

    Strategies to Improve Cancer Immune Checkpoint Inhibitors Efficacy, Other Than Abscopal Effect: A Systematic Review by Longo, Vito, Brunetti, Oronzo, Azzariti, Amalia, Galetta, Domenico, Nardulli, Patrizia, Leonetti, Francesco, Silvestris, Nicola

    Published in Cancers (15-04-2019)
    “…Despite that the impact of immune checkpoint inhibitors on malignancies treatment is unprecedented, a lack of response to these molecules is observed in…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Active notch protects MAPK activated melanoma cell lines from MEK inhibitor cobimetinib by Porcelli, Letizia, Mazzotta, Annalisa, Garofoli, Marianna, Di Fonte, Roberta, Guida, Gabriella, Guida, Michele, Tommasi, Stefania, Azzariti, Amalia

    Published in Biomedicine & pharmacotherapy (01-01-2021)
    “…[Display omitted] •Notch boosts MAPK signaling in mutated uveal and cutaneous melanoma.•Notch inhibition counteracts GNAQ-induced MAPK activation.•Galunisertib…”
    Get full text
    Journal Article
  9. 9

    Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention by Manganelli, Michele, Guida, Stefania, Ferretta, Anna, Pellacani, Giovanni, Porcelli, Letizia, Azzariti, Amalia, Guida, Gabriella

    Published in Genes (19-07-2021)
    “…Melanoma and non-melanoma skin cancers (NMSCs) are the most frequent cancers of the skin in white populations. An increased risk in the development of skin…”
    Get full text
    Journal Article
  10. 10

    Targeting Angiogenesis in Biliary Tract Cancers: An Open Option by Simone, Valeria, Brunetti, Oronzo, Lupo, Luigi, Testini, Mario, Maiorano, Eugenio, Simone, Michele, Longo, Vito, Rolfo, Christian, Peeters, Marc, Scarpa, Aldo, Azzariti, Amalia, Russo, Antonio, Ribatti, Domenico, Silvestris, Nicola

    “…Biliary tract cancers (BTCs) are characterized by a bad prognosis and the armamentarium of drugs for their treatment is very poor. Although the inflammatory…”
    Get full text
    Journal Article
  11. 11

    Tomatine Displays Antitumor Potential in In Vitro Models of Metastatic Melanoma by Serratì, Simona, Porcelli, Letizia, Guida, Stefania, Ferretta, Anna, Iacobazzi, Rosa Maria, Cocco, Tiziana, Maida, Immacolata, Tamasi, Gabriella, Rossi, Claudio, Manganelli, Michele, Tommasi, Stefania, Azzariti, Amalia, Guida, Gabriella

    “…There is a growing interest in the cytotoxic effects of bioactive glycoalkaloids, such as α-tomatine on tumor cells. Here, for the first time, we determine the…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Small-Cell Lung Cancer: Is Liquid Biopsy a New Tool Able to Predict the Efficacy of Immunotherapy? by Fasano, Rossella, Serratì, Simona, Rafaschieri, Tania, Longo, Vito, Di Fonte, Roberta, Porcelli, Letizia, Azzariti, Amalia

    Published in Biomolecules (Basel, Switzerland) (01-04-2024)
    “…Small-cell lung cancer (SCLC) cases represent approximately 15% of all lung cancer cases, remaining a recalcitrant malignancy with poor survival and few…”
    Get full text
    Journal Article
  15. 15

    New Oxaliplatin-Pyrophosphato Analogs with Improved In Vitro Cytotoxicity by Barbanente, Alessandra, Iacobazzi, Rosa Maria, Azzariti, Amalia, Hoeschele, James D, Denora, Nunzio, Papadia, Paride, Pacifico, Concetta, Natile, Giovanni, Margiotta, Nicola

    Published in Molecules (Basel, Switzerland) (04-06-2021)
    “…Two new Pt(II)-pyrophosphato complexes containing the carrier ligands -1,3-diaminocyclohexane ( -1,3-DACH) and -1,2-diamine-4-cyclohexene (1,2-DACHEX),…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Long Non-Coding RNA Landscape in Prostate Cancer Molecular Subtypes: A Feature Selection Approach by De Summa, Simona, Palazzo, Antonio, Caputo, Mariapia, Iacobazzi, Rosa Maria, Pilato, Brunella, Porcelli, Letizia, Tommasi, Stefania, Paradiso, Angelo Virgilio, Azzariti, Amalia

    “…Prostate cancer is one of the most common malignancies in men. It is characterized by a high molecular genomic heterogeneity and, thus, molecular subtypes,…”
    Get full text
    Journal Article
  20. 20

    Sigma-2 Receptor Agonists as Possible Antitumor Agents in Resistant Tumors: Hints for Collateral Sensitivity by Niso, Mauro, Abate, Carmen, Contino, Marialessandra, Ferorelli, Savina, Azzariti, Amalia, Perrone, Roberto, Colabufo, Nicola Antonio, Berardi, Francesco

    Published in ChemMedChem (01-12-2013)
    “…With the aim of contributing to the development of novel antitumor agents, high‐affinity σ2 receptor agonists were developed, with…”
    Get full text
    Journal Article